Ponalrestat: A potent and specific inhibitor of aldose reductase
- 1 January 1990
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 39 (2) , 337-346
- https://doi.org/10.1016/0006-2952(90)90033-h
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Determination of inhibition constants, I50 values and the type of inhibition for enzyme-catalyzed reactionsBiochemical Medicine and Metabolic Biology, 1988
- Regeneration and Repair of Myelinated Fibers in Sural-Nerve Biopsy Specimens from Patients with Diabetic Neuropathy Treated with SorbinilNew England Journal of Medicine, 1988
- The role of aldose reductase in the development of diabetic complicationsMedicinal Research Reviews, 1988
- Aldose reductase and ϱ‐crystallin belong to the same protein superfamily as aldehyde reductaseFEBS Letters, 1987
- Properties of ICI 128,436, a novel aldose reductase inhibitor, and its effects on diabetic complications in the ratMetabolism, 1985
- Aldehyde reductases: Monomeric NAPDH-dependent oxidoreductases with multifunctional potentialBiochemical Pharmacology, 1982
- Purification and characterization of the multiple forms of aldehyde reductase in ox kidneyBiochemical Journal, 1982
- Tight-binding inhibitors—IBiochemical Pharmacology, 1975
- A linear equation that describes the steady-state kinetics of enzymes and subcellular particles interacting with tightly bound inhibitorsBiochemical Journal, 1972
- The determination of enzyme inhibitor constantsBiochemical Journal, 1953